UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 107

Sortiert nach

Costimulatory Molecules and Immune Checkpoints Are Differentially Expressed on Different Subsets of Dendritic Cells

Frontiers in immunology, 2019-06, Vol.10, p.1325-1325

2019

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision Making

Journal of clinical oncology, 2005-10, Vol.23 (30), p.7594-7603

2005

Link zum Volltext

Verfügbarkeit prüfen

Clinical Relevance of Bone Marrow Fibrosis and CD34-Positive Cell Clusters in Primary Myelodysplastic Syndromes

Journal of clinical oncology, 2009-02, Vol.27 (5), p.754-762

2009

Link zum Volltext

Verfügbarkeit prüfen

Erythropoietin and Granulocyte-Colony Stimulating Factor Treatment Associated With Improved Survival in Myelodysplastic Syndrome

Journal of clinical oncology, 2008-07, Vol.26 (21), p.3607-3613

2008

Link zum Volltext

Verfügbarkeit prüfen

Importance of classical morphology in the diagnosis of myelodysplastic syndrome

Mediterranean journal of hematology and infectious diseases, 2015, Vol.7 (1), p.e2015035-e2015035

2015

Link zum Volltext

Verfügbarkeit prüfen

Bortezomib-based therapy in non-transplant multiple myeloma patients: a retrospective cohort study from the FABIO project

Therapeutic advances in hematology, 2021, Vol.12, p.2040620721996488

2021

Link zum Volltext

Verfügbarkeit prüfen

Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance

Haematologica (Roma), 2017-12, Vol.102 (12), p.2077-2085

2017

Link zum Volltext

Verfügbarkeit prüfen

Over-expression of mitochondrial ferritin affects the JAK2/STAT5 pathway in K562 cells and causes mitochondrial iron accumulation

Haematologica (Roma), 2011-10, Vol.96 (10), p.1424-1432

2011

Link zum Volltext

Verfügbarkeit prüfen

PB2672: EXPLORING UNMET NEEDS OF PATIENTS WITH MYELODYSPLASTIC NEOPLASMS AND CAREGIVERS IN A NATIONAL ITALIAN SURVEY

HemaSphere, 2023-08, Vol.7 (S3), p.e9792183

2023

Link zum Volltext

Verfügbarkeit prüfen

The Genetics of Myelodysplastic Syndromes: Clinical Relevance

Genes, 2021-07, Vol.12 (8), p.1144

2021

Link zum Volltext

Verfügbarkeit prüfen

Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes

European journal of haematology, 2008-03, Vol.80 (3), p.216-226

2008

Link zum Volltext

Verfügbarkeit prüfen

Myelodysplastic syndromes with bone marrow fibrosis

Haematologica (Roma), 2011-02, Vol.96 (2), p.180-183

2011

Link zum Volltext

Verfügbarkeit prüfen

Emerging Insights into Molecular Mechanisms of Inflammation in Myelodysplastic Syndromes

Biomedicines, 2023-09, Vol.11 (10), p.2613

2023

Link zum Volltext

Verfügbarkeit prüfen

Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)

Blood reviews, 2023-07, Vol.60, p.101072-101072, Article 101072

2023

Link zum Volltext

Verfügbarkeit prüfen

Generative Adversarial Networks in Brain Imaging: A Narrative Review

Journal of imaging, 2022-03, Vol.8 (4), p.83

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical relevance of extra-hematologic comorbidity in the management of patients with myelodysplastic syndrome

Haematologica (Roma), 2009-05, Vol.94 (5), p.602-606

2009

Link zum Volltext

Verfügbarkeit prüfen

Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia

Cytometry. Part B, Clinical cytometry, 2011-07, Vol.80B (4), p.201-211

2011

Link zum Volltext

Verfügbarkeit prüfen

P1638: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IS A RISK FACTOR FOR PULMONARY VASCULAR THROMBOSIS IN PATIENTS WITH COVID‐19

HemaSphere, 2023-08, Vol.7 (S3), p.e7303650-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival

Haematologica (Roma), 2009-10, Vol.94 (10), p.1391-1398

2009

Link zum Volltext

Verfügbarkeit prüfen

P499: APPLICABILITY OF 2022 CLASSIFICATIONS OF ACUTE MYELOID LEUKEMIA IN THE REAL‐WORLD SETTING

HemaSphere, 2023-08, Vol.7 (S3), p.e5402602-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(103)

Publikationsform

Sprache

Englisch
(107)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(65)
Life Sciences & Biomedicine
(63)
Humans
(58)
Hematology
(51)
Male
(25)
Female
(24)
Oncology
(23)
Aged
(17)
Middle Aged
(16)
Prognosis
(15)
Aged, 80 And Over
(13)
Biological And Medical Sciences
(12)
Myelodysplastic Syndrome
(12)
Adult
(11)
Medical Sciences
(11)
Mutation
(11)
Myelodysplastic Syndromes - Diagnosis
(11)
Myelodysplastic Syndromes - Genetics
(11)
Hematologic And Hematopoietic Diseases
(10)
Myelodysplastic Syndromes
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Costimulatory Molecules and Immune Checkpoints Are Differentially Expressed on Different Subsets of Dendritic Cells

Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision Making

Clinical Relevance of Bone Marrow Fibrosis and CD34-Positive Cell Clusters in Primary Myelodysplastic Syndromes

Erythropoietin and Granulocyte-Colony Stimulating Factor Treatment Associated With Improved Survival in Myelodysplastic Syndrome

Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study

Importance of classical morphology in the diagnosis of myelodysplastic syndrome

Bortezomib-based therapy in non-transplant multiple myeloma patients: a retrospective cohort study from the FABIO project

Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance

Second primary malignancies in ruxolitinib-treated myelofibrosis: real-world evidence from 219 consecutive patients

Over-expression of mitochondrial ferritin affects the JAK2/STAT5 pathway in K562 cells and causes mitochondrial iron accumulation

PB2672: EXPLORING UNMET NEEDS OF PATIENTS WITH MYELODYSPLASTIC NEOPLASMS AND CAREGIVERS IN A NATIONAL ITALIAN SURVEY

The Genetics of Myelodysplastic Syndromes: Clinical Relevance

S102: LUSPATERCEPT VERSUS EPOETIN ALFA FOR TREATMENT (TX) OF ANEMIA IN ESA-NAIVE LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS (PTS) REQUIRING RBC TRANSFUSIONS: DATA FROM THE PHASE 3 COMMANDS STUDY

Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes

Platelet count predicts driver mutations' co-occurrence in low JAK2 mutated essential thrombocythemia and myelofibrosis

Myelodysplastic syndromes with bone marrow fibrosis

Emerging Insights into Molecular Mechanisms of Inflammation in Myelodysplastic Syndromes

Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)

Generative Adversarial Networks in Brain Imaging: A Narrative Review

Clinical relevance of extra-hematologic comorbidity in the management of patients with myelodysplastic syndrome

Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia

P1638: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IS A RISK FACTOR FOR PULMONARY VASCULAR THROMBOSIS IN PATIENTS WITH COVID‐19

Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival

P537: SAFETY AND TOLERABILITY OF AZD0466 AS MONOTHERAPY FOR PATIENTS WITH ADVANCED HEMATOLOGICAL MALIGNANCIES ‐ PRELIMINARY RESULTS FROM AN ONGOING PHASE I/II TRIAL

P499: APPLICABILITY OF 2022 CLASSIFICATIONS OF ACUTE MYELOID LEUKEMIA IN THE REAL‐WORLD SETTING

Suchergebnisse filtern